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Abstract
Epigenetic modifications and their regulations govern the identity of every cell type 
in an organism. Cell differentiation involves a switch in gene expression profile that is 
accompanied by heritable changes of epigenetic signatures in the differentiated cell type. 
Differentiation is generally not reversible, thereby conferring cell fate decisions once an 
altered epigenetic pattern is set. Nevertheless, attempts have been made to reverse a dif-
ferentiation cell fate to a pluripotent state by various experimental approaches, such as 
somatic cell nuclear transfer, cell fusion and ectopic expression of defined transcription 
factors. The fundamental basis of all these strategies is to mediate epigenetic reprogram-
ming, which allows a permanent and completed conversion of cell fate. A comprehensive 
understanding of the dynamic of epigenetic changes during cell differentiation would 
provide a more precise and efficient way of reprogramming cell fate. Here we summarize 
the epigenetic aspects of different reprogramming strategies and discuss the possible 
mechanisms underlying these epigenetic reprogramming events.
Keywords: epigenetic, reprogramming, somatic cell nuclear transfer, cell fusion, 
transcription factors, pluripotency, differentiation, cell fate
1. Introduction
Development is a complex process that involves a series of cell differentiation pathways 
starting from totipotent embryonic cells. According to Waddington’s concept of epigenetic 
landscape, a cell has to interact with surrounding stimuli and respond by giving a pheno-
type which defines its identity during development [1]. Each cell experiences different inter/
intra-cellular signals and hence has its epigenetic signature of cell identity, which in turn 
directs its own specific gene expression pattern without alteration of DNA sequences (with 
the exception of the immunoglobulin genes in B and T cells). It is now clear that the diversity 
of cell type specific gene expression pattern is mediated by means of epigenetic mechanisms, 
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such as DNA methylation, covalent histone modifications and chromatin remodeling. Once a 
cell’s identity is set, it is difficult to convert it to other unrelated lineages, thus leading to stable 
and irreversible differentiated cell states. Nevertheless, there are a few exceptions of cell fate 
conversion during embryo development and adult tissue/organ regeneration, e.g. vascular 
endothelium to smooth muscle cells [2], which involve changing a cell’s epigenetic signature 
into another unrelated kind.
Apart from a few exceptions of natural cell fate conversion events, different strategies have 
been developed aiming to reprogram differentiated somatic cell fate to a pluripotent state 
(Figure 1). A historical strategy of reprogramming is by somatic cell nuclear transfer (SCNT) 
experiments. SCNT involves transplantation of a cell nucleus into an enucleated egg/oocyte 
in order to generate a “cloned” animal with an equivalent genetic composition as the donor 
individual. It is possible to derive embryonic stem (ES) cells from nuclear transplanted (NT) 
embryos (ntES cells), which shows indistinguishable pluripotent gene expression profiles 
Figure 1. Strategies of reprogramming cell fate. Differentiated cells can be reprogrammed to pluripotent state by 
somatic cell nuclear transfer (SCNT), cell fusion, and ectopic expression of defined transcription factors. SCNT involves 
transplantation of a single differentiated cell nucleus into an enucleated egg/oocyte, which develops as a nuclear 
transplanted (NT) embryo. Cell fusion involves artificial fusion of a differentiated and a pluripotent cell to form a 
tetraploid pluripotent-like cell. Defined transcription factors (Oct4, Sox2, Klf4, c-Myc) can be ectopically expressed in 
differentiated cells and convert them to induced pluripotent stem (iPS) cells.
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when compared to the normal ES cells derived from fertilized embryos. Another strategy of 
reprogramming is achieved by fusion of a differentiated cell with a pluripotent cell in order 
to generate a pluripotent-like tetraploid hybrid cell [3–5]. It has been proposed that cellular 
components, such as transcription factors, in the pluripotent cell are able to reprogram the 
differentiated cell nucleus. This idea aligns with the use of cell extracts from pluripotent cell 
types to revert differentiated cells into a pluripotent-like state [6, 7]. Presumably the cyto-
plasmic “reprogramming factors” from the pluripotent cells can be isolated and concentrated 
to achieve a higher reprogramming efficacy. A third strategy involves ectopic expression 
of defined transcription factors in somatic differentiated cells to generate induced pluripo-
tent stem (iPS) cells. Delivery of the ectopic transcription factors can be achieved by viral 
approaches, such as the use of retrovirus, lentivirus, adeno-associated virus or Sendai virus, 
or by using episomal vesicles, or by direct mRNA or protein transfection. This technique has 
been successfully applied to reprogram a vast number of differentiated somatic cell types. 
Importantly, iPS cells can also be generated by using combinations of microRNAs (miRNAs) 
or small chemical molecules without the needs of ectopic expression of reprogramming fac-
tors [8]. The three reprogramming strategies show different reprogramming kinetics and 
efficiencies, which can be associated with the distinct epigenetic mechanisms in the erasure of 
somatic cell epigenetic signature and re-establishment of the pluripotent one. In this review, 
we focus on the dynamic changes of epigenetics mediated by different reprogramming strate-
gies and how the modulation of epigenetic status improves the reprogramming efficiency.
2. Epigenetic reprogramming by SCNT
SCNT was first done by Briggs and Kings in 1952, who transplanted a blastula nucleus into 
an enucleated egg of the amphibian Rana pipiens [9]. Few years later, Gurdon et al. succeeded 
by using differentiated Xenopus intestinal epithelial donor nuclei for SCNT [10]. In 1997, 
the first cloned mammal, Dolly the sheep, was generated [11], and since then, more than 
23 other mammalian species have now been successfully cloned [12]. Normal development 
of nuclear transplanted (NT) embryos requires recapitulation of the gene expression profile 
that supports the embryogenesis process by the differentiated donor nucleus. This involves 
re- activation of pluripotency genes, in particular Oct4, Nanog and Sox2, and repression of 
somatic lineage genes. In fact, the efficiency of reprogramming by SCNT is generally very low 
and less than 1% of NT embryos can develop into normal adults [13–15]. The cloned newborns 
often suffer from developmental abnormalities owing to incomplete reprogramming. It has 
been observed that Oct4 was aberrantly expressed in cloned mouse blastocysts derived from 
cumulus donor nuclei [16, 17]. Besides, continuous expression of other somatic donor marker 
genes was demonstrated in some Xenopus NT embryos [18]. Some imprinted genes in donor 
cells were found to be aberrantly expressed in cloned embryos, presumably owing to the 
incomplete epigenetic reprogramming of the regulatory regions of imprinting loci [19–21]. 
Dysregulation of imprinted genes, such as Igf2, Igf2r, H19, and Xist, in cloned embryos can 
lead to both fetal and placental overgrowth and result in embryonic lethality or an abnormal 
growth condition called “large offspring syndrome”, which is commonly found in cloned 
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mammals [22–24]. Since the SCNT process does not increase the frequency of genetic altera-
tions, it is suggested that the variable phenotypes observed in cloned embryos are associated 
with the reprogrammed epigenetic status of the donor nuclei [25]. This is supported by the 
findings that the developmental defects in cloned animals were not transmittable to the next 
offspring generation, indicating the presence of aberrant epigenetic reprogramming [26]. 
Aberrant DNA methylation patterns were indeed observed in NT embryos [27]. It was also 
demonstrated that the bovine NT blastocysts lack asymmetric patterns of both H3K9 methyla-
tion and acetylation between the inner cell mass and trophectoderm [28], which may account 
for abnormal cloned embryo development.
Although the rate of successful SCNT is very low, the reprogramming ability of factors in the 
egg/oocyte is highly efficient as the transplanted nuclei take less than 1 day to initiate cell divi-
sion and trigger the “normal” developmental program. The donor cell epigenetic status has to 
be reprogrammed in order to support the embryonic program of development. In fact, genome-
wide demethylation was observed in the cloned blastocysts [29]. It has been shown that the Oct4 
promoter of somatic cells undergoes DNA demethylation after nuclear transplantation into the 
germinal vesicle of Xenopus oocytes [30]. This demethylation of the Oct4 promoter was found to 
be mediated by Tet3 in a mouse SCNT study [31], which is essential for the reactivation of Oct4 
expression for successful SCNT. In addition, chromatin remodeling factors, such as ISWI and 
BRG1, are documented in facilitating the reprogramming of cell fate. It has been shown that 
ISWI, which is a chromatin remodeling ATPase, is able to dissociate TATA binding protein in 
somatic nuclei after incubation in the Xenopus egg extract, suggesting that ISWI-containing com-
plexes are facilitating epigenetic reprogramming in an egg environment [32]. Besides, Xenopus 
egg extract depleted of BRG1 protein showed an abolishment of the reprogramming ability and 
hence failed to induce Oct4 expression in the somatic nuclei [33]. Therefore, chromatin structure 
remodeling is believed to be one of the reprogramming mechanisms. In addition, the maternal-
derived histone H3 variant H3.3 in the enucleated egg was found to replace the canonical his-
tone H3 in the donor nuclei after SCNT, leading to the reactivation of key pluripotent genes that 
are originally associated with repressive histone marks [34]. Histone H2A variant, macroH2A, 
also plays an important role in the reactivation of female donor cell’s inactive X chromosome 
during reprogramming. It was shown that knockdown of macroH2A facilitates X-reactivation 
and the expression of pluripotent genes in cloned Xenopus embryos [35]. More recently, it has 
been demonstrated that the H3K9 tri-methylation (H3K9me3) of the donor cell genome is a 
major epigenetic barrier to SCNT. Ectopic expression of H3K9 demethylases Kdm4b or Kdm4d 
in the mouse donor cells de-repressed the genomic regions that are resistant to reprogramming 
and thus significantly improving SCNT efficiency [36, 37]. Similarly, removal of H3K9me3 by 
ectopic expression of other H3K9 demethylases also demonstrated improved reprogramming 
efficiency in human and bovine SCNT experiments [38, 39].
Interestingly, it has been shown that the epigenetic state of a differentiated cell is directly 
correlated with its reprogrammability [40]. SCNT with ES cell nuclei demonstrated a much 
higher efficiency of generation of NT blastocysts than using other somatic cell types [41]. This 
could be associated with a more relaxed chromatin configuration in ES cells that may render 
their epigenome more susceptible for reprogramming [42]. Alternatively, it has been dem-
onstrated that the cloning efficiency can be significantly improved by pre-treating the more 
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differentiated and condensed chromatin state of somatic nuclei with epigenetic modifying 
agents, e.g. 5-aza-deoxycytidine and trichostatin A (TSA), that facilitate chromatin relaxation 
[43–45]. Interestingly, the effect of TSA treatment in improving SCNT is associated with the 
reactivation of a subset of genes that are repressed by H3K9me3 in the somatic cells [46], pre-
sumably through introducing histone hyper-acetylation at their promoters. Altogether, SCNT 
provides a quick route of epigenetic reprogramming for a differentiated cell to a pluripotent 
state. Identification of the responsible reprogramming factors in the egg and oocyte cytoplasm 
will be one of the key future directions to improve the efficiency of SCNT and therapeutic 
cloning.
3. Epigenetic reprogramming by cell fusion
Cell fusion is a natural event that is crucial for fertilization and in various organs such as pla-
centa, skeletal muscles and bones [47]. It has been proposed that the fusion of bone marrow-
derived stem cells and tissue cells, e.g. hepatocytes, is one of the mechanisms of tissue repair 
[48, 49]. Cell fusion experiments using pluripotent cells, e.g. an ES or embryonic germ (EG) 
cell, were shown to be able to reprogram a differentiated cell type [3–5]. Both ES and EG cells 
possess reprogramming ability and are able to reactivate pluripotent genes and silence differ-
entiation genes in the somatic cell nucleus within a tetraploid hybrid cell after cell fusion. It is 
indeed the case that the new transcription profile of a hybrid cell is partly contributed by the 
reprogrammed somatic nucleus to a pluripotent-like state. Moreover, injection of hybrid cells 
into normal diploid blastocysts demonstrated their contribution to all three germ layers in the 
chimeras [4, 50], indicating the pluripotent nature of hybrid cells. Similar to the SCNT, differ-
ent somatic cell types show different kinetics of reprogramming by the cell fusion approach, 
which could be associated with the somatic chromatin accessibility status [51, 52].
Cell fusion with a pluripotent cell can trigger extensive epigenetic reprogramming in the differ-
entiated cell nucleus. It has been shown that reactivation of Oct4 from the somatic nucleus occurs 
before DNA replication after cell fusion [53], suggesting the involvement of active demethylation 
process [54]. This was further supported by the functional roles of Tet1 and Tet2 in the demethyl-
ation of Oct4 and imprinted control regions by fusing somatic cells with EG cells [55]. Besides, in 
a cell fusion experiment using thymocytes and ES cells from two different mouse strains, it was 
observed that the epigenetic profile of the somatic cell nucleus was reprogrammed to a similar pat-
tern to that of the ES cell. Global histone H3 and H4 acetylation and H3K4 di- and tri- methylation 
were increased in the hybrid cell to a level comparable to ES cells, whereas these modifications 
are weak in the parental somatic thymocytes. Examination of gene specific loci showed that the 
Oct4 promoter was enriched with H3 acetylation and the promoter of the thymocyte marker Thy-
1 was enriched with H3K27 tri-methylation in both ES cell and hybrid cell chromatin, whereas 
these epigenetic modifications are missing in the thymocyte [56]. Hence, the somatic genome has 
undergone epigenetic reprogramming triggered by fusion with the ES cell, suggesting that the 
process of cell fusion mediates a transcription activation-permissive chromatin state in the hybrid 
genome. In addition, silencing the somatic differentiation genes was shown to be associated with 
polycomb repressive complexes in the cell fusion experiment using ES cells [57].
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Reprogramming to pluripotency by cell fusion approach requires lengthy selection of the suc-
cessfully reprogrammed hybrid cells. The reprogramming efficiency of cell fusion is usually 
less than 0.001%, depending on the somatic cell types [50, 58]. The low reprogramming effi-
ciency in hybrid cells can be largely enhanced by manipulation of key pluripotency-associated 
genes like Nanog [58, 59] and Sall4 [60], or by activation of the Wnt signaling pathway [61], 
emphasizing the importance of these factors in cell fusion reprogramming. Overexpression 
of Nanog or Sall4 in ES cells demonstrated a several hundred-fold increase in reprogram-
ming efficiency after cell fusion. Similarly, treatment of ES cells with Wnt3a for 24–48 hours 
enhanced the reprogramming of somatic cells by 20-fold. However, owing to the low repro-
gramming efficiency and the tetraploid genome of the resulting hybrid cells, reprogramming 
by the cell fusion approach becomes less promising in regenerative medicine.
4. Epigenetic reprogramming by defined transcription factors
In a groundbreaking discovery, Yamanaka et al. demonstrated that somatic cell state can be 
reprogrammed to a pluripotent state by the introduction of only four transcription factors; 
Oct4, Sox2, Klf4 and c-Myc, which are now also known as the Yamanaka factors. The first gen-
eration of iPS cells was obtained using a Fbx15-driven selection construct (Fbx15-iPS) and dis-
played a gene expression pattern very similar to that of normal pluripotent ES cells. However, 
the somatic epigenetic signature was only partially reprogrammed; the Oct4 promoter, for 
example, retained some DNA methylation and no germline transmission was observed for 
these cells in chimeric mice. Hence these first-generation iPS cells were not fully pluripotent in 
nature [62]. Given the potential reprogramming capacity of these four factors, the second gen-
eration of iPS cells was generated by selection with a Nanog reporter construct (Nanog-iPS) 
[63, 64]. During the reprogramming process, the virally delivered transgenes were silenced, 
but on the contrary, the endogenous Oct4 and Sox2 loci were re-activated for the maintenance 
of pluripotency in iPS cells. In contrast to the Fbx15-iPS cells, these Nanog-iPS cells were able 
to undergo germline transmission in chimeric mice, and thus share this crucial feature of 
pluripotency with normal ES cells. These landmark studies that pioneered the derivation of 
mouse iPS cells led to the possibility of using the same strategy to generate human iPS cells. 
An initial study was performed by Thomas et al. in which a different combination of factors, 
OCT4, SOX2, NANOG and LIN28, was used to reprogram human fibroblasts into iPS cells 
[65]. Thereafter, Yamanaka and other groups succeeded in generating human iPS cells by 
using the same 4 Yamanaka factors as in the mouse iPS systems [66, 67]. To date, a number of 
different somatic cell types have been successfully reprogrammed into iPS cells, e.g. neural 
stem cells, keratinocytes, hepatocytes, gastric epithelia cells, pancreatic β cells, terminally dif-
ferentiated B and T cells [8].
By using the defined transcription factor approach to reprogram cell fate, about 0.1–3% of 
the somatic starting cell population can be converted into iPS cells in around 2–3 weeks. The 
reprogramming efficiency is believed to be correlated with the differentiation state of the 
starting somatic cells. It has been shown that hematopoietic stem and progenitor cells can be 
reprogrammed to iPS cells 300 times more efficient than the terminally differentiated B and 
T cells [68]. Interestingly, partially de-differentiating mature B cells by either knockdown of 
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Pax5 or forced expression of C/EBPα resulted in efficient reprogramming by the Yamanaka 
factors [69], suggesting that the epigenetic status of differentiated cells is crucial in successful 
reprogramming. The dynamics of transcription profile and epigenetic patterns during the 
reprogramming process from somatic to iPS cells were studied in details. The reprogramming 
of somatic cell fate is a sequential stochastic event which involves a gradual silencing of the 
somatic lineage genes and the viral transgenes, and a sequential expression of alkaline phos-
phatase and SSEA1 in partially reprogrammed cells, whereas endogenous Oct4 and Nanog 
are only activated in fully reprogrammed iPS cells. Induction of the four Yamanaka factors 
results in an immediate cellular response of inactivation of thousands of somatic lineage 
distal enhancers and, to a smaller extent, the H3K4me3-enriched somatic gene promoters 
[70, 71], leading to down-regulation of somatic identity genes. This initial phase of repro-
gramming is also accompanied by a global reduction of H3K27me3 resulting in loss of het-
erochromatin [72]. Meanwhile, mesenchymal transcription factors, such as Snail1/2, Zeb1/2, 
are repressed [70, 73, 74], whereas epithelial transcription factors, such as Cdh1, Epcam, are 
activated [75, 76], resulting in mesenchymal-epithelial transition (MET). This is associated 
with an increase in H3K4me2 at epithelial genes, but a decrease in H3K4me2 and H3K79me2 
at mesenchymal genes [71, 77]. Despite an increase in global H3K36me2/3 level, loss of 
H3K36me2/3 was observed at the Ink4-Arf locus, leading to enhanced cell proliferation during 
reprogramming [78]. The following phase of reprogramming is marked by upregulation of 
endogenous pluripotency genes to establish transcriptional program, which is independent 
of transgene expression [73, 79]. The final phase of reprogramming involves elongation of 
telomeres, X-reactivation in female iPS cells, and upregulation of DNA methylation genes 
[79]. This coincides with loss of DNA methylation and downregulation of Xist expression in 
the somatic inactive X chromosome [80, 81].
A number of epigenetic remodeling factors are involved in the reprogramming events. Both 
polycomb (PcG) and trithorax (TrxG) group proteins were found to be crucial in the derivation 
of iPS cell colonies. Upon knockdown of Wdr5, which is a core component of TrxG protein 
complex, cells failed to establish H3K4me3 at the pluripotent genes, like Oct4 and Nanog, for 
their reactivation [82]; whereas inhibition of the core components of the polycomb repressive 
complex 1 and 2 reduced reprogramming efficiency [83], partly because of the dysregulation of 
genes involved in the MET process [84]. This is similar to the findings that inhibition of H3K79 
methyltransferase DOT1L facilitates the loss of H3K79me2 mark at the mesenchymal genes 
to promote MET during reprogramming [83]. The H3K27 demethylase Kdm6a (also known 
as Utx) can directly interact with Oct4/Sox2/Klf4 to remove the repressive H3K27me3 mark 
from the early pluripotent genes in somatic cells for their reactivation [85]. This is in agreement 
with the findings that depletion of histone H2A variant, macroH2A, enhances reprogramming, 
owing to its co-occupancy with H3K27me3 to repress pluripotent genes [86, 87]. Besides, the 
H3K36 demethylase Kdm2b (also known as Jhdm1b) enhances the activation of early respon-
sive genes (Cdh1, Epcam, Dsg2, Dsp, Irf6) during reprogramming through the removal of 
H3K36me2 at their promoters [88]. Interestingly, H3K9me3 was also found to be one of the 
major epigenetic barriers in the generation of iPS cells [89], similar to the findings in SCNT 
experiments. Depletion of the H3K9 methyltransferases SUV39H1/H2, Ehmt1/2 and Setdb1 or 
inhibition of Cbx3, a protein that recognizes H3K9 methylation, enhances reprogramming by 
de-repressing Nanog and abolishing the cellular responses to BMP signaling [89–91]. Although 
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Dnmt3a/b were found to be dispensable [92], DNA demethylation of key pluripotency loci 
mediated by Tet proteins is required for efficient reprogramming [93–95].
Previous studies demonstrated that the partially reprogrammed iPS cells contained signifi-
cantly fewer genes marked by the bivalent chromatin signature (co-existence of both H3K4 
and H3K27 methylation) and an enrichment of DNA hyper-methylated loci when compared 
to the wild-type ES cells and the fully reprogrammed iPS cells [70]. Therefore, it is proposed 
that completion of the epigenetic reprogramming process is pre-requisite for the acquisition of 
pluripotency. This is supported by the observation that treatment of partially reprogrammed 
iPS cells with the DNA methyltransferase inhibitor 5-aza-cytidine was able to promote their 
transition into the fully reprogrammed pluripotent state [70]. Besides, inhibition of H3K27 
methyltransferase Ezh2 by small molecule, GSK-126, reduced reprogramming efficiency [84], 
whereas inhibition of DOT1L by small molecule, EPZ004777, showed enhancement of repro-
gramming [83]. Various histone deacetylase inhibitors (HDACi) were also shown to improve 
reprogramming [96–100]. In combination with HDACi valproic acid, human iPS cells can be 
generated only with Oct4 and Sox2 with a comparable reprogramming efficiency by the four 
Yamanaka factors [101]. Interestingly, it was found that vitamin C can increase reprogram-
ming efficiency by promoting the transition of pre-iPS cells to fully reprogrammed cells [102], 
potentially through acting as a cofactor of Kdm2b to induce H3K36me2/3 demethylation [78], 
activation of H3K9 demethylases (Kdm3a, 3b, 4c and 4d) to remove H3K9me3 [89], and pro-
moting Tet-mediated DNA demethylation [103]. With the aid of small chemical molecules, the 
iPS cell reprogramming efficiency and duration could be further improved.
5. “Epigenetic memory” in reprogrammed cells
“Epigenetic memory” refers to the persistent expression of parental genes in the daughter 
cells through the inheritance of distinctive epigenetic marks. Consequently, the epigenetic 
profile of a parent cell is faithfully passed on to its daughter cells such that the gene expression 
pattern is memorized and maintained throughout cell generations. In the situation of repro-
gramming cell fate, the persistent somatic cell epigenetic signature and the expression of lin-
eage genes in the reprogrammed cells is thus regarded as an example of epigenetic memory.
Even though it has been shown that prolonged in vitro culture of mammalian embryos can 
lead to aberrant expression of imprinted and non-imprinted genes owing to associated epi-
genetic ‘errors’ [104, 105]. It has been shown that many cloned embryos demonstrate differ-
ent degrees of resemblance with donor cell gene expression patterns. The aberrant epigenetic 
pattern in cloned embryos is thought to be the result of persistence of the epigenetic memory 
of the donor cells. Indeed, the resemblance of DNA and histone modification patterns of NT 
embryos to those of the donor cell types supports this conclusion [45–47]. For example, both 
global and gene-specific patterns of DNA methylation in cloned bovine and mouse embryos 
were shown to be similar to those of their respective donor somatic cell types [28, 106, 107]. The 
phenomenon of epigenetic memory is also highlighted by the X inactivation pattern in cloned 
embryos. In normal fertilized embryos, the paternal X chromosome is preferentially silenced 
in the trophectoderm and extraembryonic endoderm lineages, whereas random X inactivation 
occurs in the inner cell mass. However, in NT embryos generated from female donor nuclei, the 
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inactive X chromosome of the donor cell is preferentially chosen for inactivation in the trophec-
toderm, which is in contrast to the random X inactivation in the embryo proper, demonstrating 
a certain extent of memory of the inactive X chromosome status [48]. Random X inactivation in 
the placenta was found in deceased cloned bovine embryos, which suggests that the persistence 
of this inactive X chromosome memory in the placenta may be crucial for fetal survival [49].
The epigenetic memory in NT embryos that maintains the donor expression gene states can 
be explained by the inheritance of DNA methylation patterns. Heritability of DNA methyla-
tion is mediated by the activity of the maintenance DNA methyltransferase Dnmt1 which 
preferentially targets hemi-methylated DNA. Thus, Dnmt1 restores the parental methylation 
status on the newly synthesized daughter DNA strand, thereby maintaining a silent gene 
state after cell division [108]. Methylated donor genes, such as pluripotency genes, remain 
inactivated after SCNT, apparently owing to the persistent donor-specific methylation pattern 
in the cloned embryos, possibility mediated by the residual somatic form of Dnmt in the donor 
nucleus. DNA methylation therefore provides a plausible mechanism for the propagation of 
a silent memory state in SCNT [109]. On the other hand, an active gene memory of the donor 
differentiation state is also observed in NT embryos. For example, both the donor endoderm 
and neurectoderm markers, Edd and Ncam, were found to be aberrantly expressed in Xenopus 
NT embryos derived from the respective donor cell types [18]. This active gene memory was 
further demonstrated to be associated with the incorporation of a histone H3 variant H3.3 at 
the active gene loci in Xenopus NT embryos [110]. Histone variant H3.3 is enriched in the regu-
latory region of active genes and is preferentially marked by modifications associated with an 
active chromatin state, such as H3K4 methylation, H3K9 acetylation and H3K79 methylation 
[111, 112]. Experiments using a mutant form of H3.3 demonstrated that the K4 residue on 
H3.3 plays a key role in the inheritance of active epigenetic memory [110], proposing a model 
in which H3.3 K4 methylation creates an “active histone environment” for the recovery of 
active chromatin configuration in daughter cells after chromosomal replication [113].
Early studies of iPS cells demonstrated that the Nanog-iPS cells displayed not only a 
highly similar transcriptome to wild-type ES cells, but also an ES cell histone modifica-
tion profile. Genome-wide comparison of histone modifications (H3K4 and H3K27 tri-
methylation) between ES cells, MEFs and MEF-derived iPS cells demonstrated that more 
than 94% of the ES- or MEF-signature genes in iPS cells have identical histone methyla-
tion marks as in ES cells. Only 0.7% of these signature genes retain the histone methyla-
tion status of the original MEFs [63]. However, other gene expression profile studies of iPS 
cells showed that a significant number of differentiation genes have a similar expression 
pattern to that in the somatic cell of origin, but not in ES cells [114–117]. This transcrip-
tional memory in iPS cells was found to be correlated with biased differentiation towards 
the original cell lineage, and with less competence in differentiation to other unrelated 
somatic lineages [115, 118–121]. Importantly, the persistent expression of somatic genes 
in iPS cells was associated with the somatic DNA methylation pattern [117, 122–124], 
highlighting the crucial role of epigenetic regulation in the retention of memory. This is 
in fact similar to the observation that an incomplete removal of donor cell DNA meth-
ylation pattern was observed in some aberrantly developed NT embryos [125]. Strikingly, 
the addition of epigenetic modifying agents, such as DNA methyltransferase inhibitor 
5-aza-2’-deoxycytidine (5-aza-dC), can enhance the iPS cell reprogramming efficiency [70] 
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and improve the differentiation competency to other unrelated somatic lineages [120]. 
Interestingly, it has been demonstrated that continuous passaging of iPS cells abrogates 
somatic DNA methylation patterns [115], which suggests a passive replication-dependent 
mechanism in loss of the parental memory in iPS cells. Nevertheless, a study showed that the 
epigenetic memory in some iPS cell lines cannot be removed even after extended passages 
[124]. Apart from DNA methylation, microRNA expression pattern was also shown to have a 
role in the retention of somatic memory in iPS cells derived from hematopoietic progenitors 
[126]. However, it should be emphasized that other profiling studies of iPS cells failed to find 
the gene expression and epigenetic differences when compared to ES cells [127, 128]. It thus 
proposes that the “somatic memory” in iPS cells could be an artifact of incomplete repro-
gramming resulting in variation between iPS cell lines [129]. It is also possible that there 
are individual iPS cell lines expressing gene signatures owing to culture conditions and 
laboratory practices [130], similar to the scenario that some ES cell lines exhibit preferential 
differentiation towards specific lineages [131–133]. In summary, the epigenetic memory in 
iPS cells remains a contentious issue.
6. Conclusions and perspectives
Although the term “epigenetic landscape” was first introduced by Waddington in 1942 [1], 
our understanding of how the epigenome of a cell type is maintained and altered during 
differentiation is still far from complete. The reversal of the differentiated state of a cell has 
important implications for our understanding of normal development and for regenerative 
medicine. Epigenetic reprogramming provides heritable changes of cell identity, and thus 
is a key event for the complete and permanent conversion of cell fate (Figure 2). Although 
reprogramming of cell fate can be achieved by different strategies, the rate (reprogramming 
time) and efficiency (number of reprogrammed cells) are far from comparable to the natural 
event during fertilization/de-differentiation. Achieving a complete epigenetic reversion to 
generate reprogrammed cells or iPS cells with a comparable potency state of early embryos 
would imply that these cells can respond correctly to differentiation-promoting signals, and 
more importantly, decrease the tumorigenic potential owing to pre-disposing epimutations. 
Notably, the status of epigenetic memory in iPS cells can be regarded as a state of incom-
plete reprogramming. The biased differentiation owing to the persistent somatic epigenetic 
memory in iPS cells might be useful in efficient differentiation to the desired cell type of 
origin, which usually results in a heterogeneous cell population by using un-optimized dif-
ferentiation protocols. On the contrary, it has been shown that in vitro culture condition can 
alter the epigenetic status of iPS cells [134]. With an optimized culture condition, a more 
homogeneous population of iPS cells can be obtained, which corresponds to the naïve state 
of pluripotency, and hence, further abrogate the somatic “epigenetic memory”. A more 
recent approach in reprogramming involves the use of a combination of small chemical 
molecules and epigenetic modifying agents, without any ectopic expression of transcrip-
tion factors [135, 136]. This approach seems to induce pluripotent reprogramming process 
different from the transcription factor-mediated approach. Therefore, unlocking the secrets 
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of epigenetic resetting mechanisms during cell differentiation can shed light on the develop-
ment of more efficient and complete reprogramming approaches to further advance regen-
erative medicine.
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Figure 2. Mechanisms of epigenetic reprogramming. Epigenetic patterns in differentiated cells need to be reprogrammed 
to those of pluripotent cells, which results in silencing of differentiated genes and reactivation of pluripotency genes. 
Epigenetic reprogramming can be achieved by modulation of DNA methylation and histone modifications by various 
epigenetic modifying enzymes, such as Dnmt, Tet, Kdm2b, Kdm4b, Utx, Ezh2 (PcG), histone variant replacement, and 
chromatin remodeling enzymes. Other epigenetic mechanisms may also be involved. It is believed that a collaborative 
contribution of different epigenetic mechanisms is required for complete reversal of the differentiated cell state.
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